Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.

The global Gene Therapy For Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Gene Therapy For Cancer in Cancer Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Gene Therapy For Cancer include GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis and Chimeron, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Cancer.

Report Scope

The Gene Therapy For Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy For Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy For Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy For Cancer Market Report

Report Metric	Details
Report Name	Gene Therapy For Cancer Market
Segment by Type	Rb Gene P53 Gene APC Gene NF1 Gene Others
Segment by Application	Cancer Treatment Tissue Repair Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis, Chimeron
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy For Cancer Market report?

Ans: The main players in the Gene Therapy For Cancer Market are GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis, Chimeron

What are the Application segmentation covered in the Gene Therapy For Cancer Market report?

Ans: The Applications covered in the Gene Therapy For Cancer Market report are Cancer Treatment, Tissue Repair, Others

What are the Type segmentation covered in the Gene Therapy For Cancer Market report?

Ans: The Types covered in the Gene Therapy For Cancer Market report are Rb Gene, P53 Gene, APC Gene, NF1 Gene, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy For Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Rb Gene

1.2.3 P53 Gene

1.2.4 APC Gene

1.2.5 NF1 Gene

1.2.6 Others

1.3 Market by Application

1.3.1 Global Gene Therapy For Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancer Treatment

1.3.3 Tissue Repair

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy For Cancer Market Perspective (2019-2030)

2.2 Gene Therapy For Cancer Growth Trends by Region

2.2.1 Global Gene Therapy For Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Therapy For Cancer Historic Market Size by Region (2019-2024)

2.2.3 Gene Therapy For Cancer Forecasted Market Size by Region (2025-2030)

2.3 Gene Therapy For Cancer Market Dynamics

2.3.1 Gene Therapy For Cancer Industry Trends

2.3.2 Gene Therapy For Cancer Market Drivers

2.3.3 Gene Therapy For Cancer Market Challenges

2.3.4 Gene Therapy For Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy For Cancer Players by Revenue

3.1.1 Global Top Gene Therapy For Cancer Players by Revenue (2019-2024)

3.1.2 Global Gene Therapy For Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Gene Therapy For Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy For Cancer Revenue

3.4 Global Gene Therapy For Cancer Market Concentration Ratio

3.4.1 Global Gene Therapy For Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Cancer Revenue in 2023

3.5 Gene Therapy For Cancer Key Players Head office and Area Served

3.6 Key Players Gene Therapy For Cancer Product Solution and Service

3.7 Date of Enter into Gene Therapy For Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy For Cancer Breakdown Data by Type

4.1 Global Gene Therapy For Cancer Historic Market Size by Type (2019-2024)

4.2 Global Gene Therapy For Cancer Forecasted Market Size by Type (2025-2030)

5 Gene Therapy For Cancer Breakdown Data by Application

5.1 Global Gene Therapy For Cancer Historic Market Size by Application (2019-2024)

5.2 Global Gene Therapy For Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Therapy For Cancer Market Size (2019-2030)

6.2 North America Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene Therapy For Cancer Market Size by Country (2019-2024)

6.4 North America Gene Therapy For Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy For Cancer Market Size (2019-2030)

7.2 Europe Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene Therapy For Cancer Market Size by Country (2019-2024)

7.4 Europe Gene Therapy For Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy For Cancer Market Size (2019-2030)

8.2 Asia-Pacific Gene Therapy For Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy For Cancer Market Size (2019-2030)

9.2 Latin America Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene Therapy For Cancer Market Size by Country (2019-2024)

9.4 Latin America Gene Therapy For Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy For Cancer Market Size (2019-2030)

10.2 Middle East & Africa Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GLIEAD

11.1.1 GLIEAD Company Detail

11.1.2 GLIEAD Business Overview

11.1.3 GLIEAD Gene Therapy For Cancer Introduction

11.1.4 GLIEAD Revenue in Gene Therapy For Cancer Business (2019-2024)

11.1.5 GLIEAD Recent Development

11.2 REGENXBIO

11.2.1 REGENXBIO Company Detail

11.2.2 REGENXBIO Business Overview

11.2.3 REGENXBIO Gene Therapy For Cancer Introduction

11.2.4 REGENXBIO Revenue in Gene Therapy For Cancer Business (2019-2024)

11.2.5 REGENXBIO Recent Development

11.3 Autolus

11.3.1 Autolus Company Detail

11.3.2 Autolus Business Overview

11.3.3 Autolus Gene Therapy For Cancer Introduction

11.3.4 Autolus Revenue in Gene Therapy For Cancer Business (2019-2024)

11.3.5 Autolus Recent Development

11.4 American Gene Technologies

11.4.1 American Gene Technologies Company Detail

11.4.2 American Gene Technologies Business Overview

11.4.3 American Gene Technologies Gene Therapy For Cancer Introduction

11.4.4 American Gene Technologies Revenue in Gene Therapy For Cancer Business (2019-2024)

11.4.5 American Gene Technologies Recent Development

11.5 Arcellx

11.5.1 Arcellx Company Detail

11.5.2 Arcellx Business Overview

11.5.3 Arcellx Gene Therapy For Cancer Introduction

11.5.4 Arcellx Revenue in Gene Therapy For Cancer Business (2019-2024)

11.5.5 Arcellx Recent Development

11.6 AUSTRIANOVA

11.6.1 AUSTRIANOVA Company Detail

11.6.2 AUSTRIANOVA Business Overview

11.6.3 AUSTRIANOVA Gene Therapy For Cancer Introduction

11.6.4 AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2019-2024)

11.6.5 AUSTRIANOVA Recent Development

11.7 Alphavax

11.7.1 Alphavax Company Detail

11.7.2 Alphavax Business Overview

11.7.3 Alphavax Gene Therapy For Cancer Introduction

11.7.4 Alphavax Revenue in Gene Therapy For Cancer Business (2019-2024)

11.7.5 Alphavax Recent Development

11.8 Cellectis

11.8.1 Cellectis Company Detail

11.8.2 Cellectis Business Overview

11.8.3 Cellectis Gene Therapy For Cancer Introduction

11.8.4 Cellectis Revenue in Gene Therapy For Cancer Business (2019-2024)

11.8.5 Cellectis Recent Development

11.9 Chimeron

11.9.1 Chimeron Company Detail

11.9.2 Chimeron Business Overview

11.9.3 Chimeron Gene Therapy For Cancer Introduction

11.9.4 Chimeron Revenue in Gene Therapy For Cancer Business (2019-2024)

11.9.5 Chimeron Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GLIEAD

REGENXBIO

Autolus Limited

American Gene Technologies

List of Tables

Table 1. Global Gene Therapy For Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Rb Gene

Table 3. Key Players of P53 Gene

Table 4. Key Players of APC Gene

Table 5. Key Players of NF1 Gene

Table 6. Key Players of Others

Table 7. Global Gene Therapy For Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Gene Therapy For Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Gene Therapy For Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Gene Therapy For Cancer Market Share by Region (2019-2024)

Table 11. Global Gene Therapy For Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Gene Therapy For Cancer Market Share by Region (2025-2030)

Table 13. Gene Therapy For Cancer Market Trends

Table 14. Gene Therapy For Cancer Market Drivers

Table 15. Gene Therapy For Cancer Market Challenges

Table 16. Gene Therapy For Cancer Market Restraints

Table 17. Global Gene Therapy For Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Gene Therapy For Cancer Market Share by Players (2019-2024)

Table 19. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2023)

Table 20. Ranking of Global Top Gene Therapy For Cancer Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Gene Therapy For Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Gene Therapy For Cancer Product Solution and Service

Table 24. Date of Enter into Gene Therapy For Cancer Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Gene Therapy For Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Gene Therapy For Cancer Revenue Market Share by Type (2019-2024)

Table 28. Global Gene Therapy For Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Gene Therapy For Cancer Revenue Market Share by Type (2025-2030)

Table 30. Global Gene Therapy For Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Gene Therapy For Cancer Revenue Market Share by Application (2019-2024)

Table 32. Global Gene Therapy For Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Gene Therapy For Cancer Revenue Market Share by Application (2025-2030)

Table 34. North America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Gene Therapy For Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 49. GLIEAD Company Detail

Table 50. GLIEAD Business Overview

Table 51. GLIEAD Gene Therapy For Cancer Product

Table 52. GLIEAD Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 53. GLIEAD Recent Development

Table 54. REGENXBIO Company Detail

Table 55. REGENXBIO Business Overview

Table 56. REGENXBIO Gene Therapy For Cancer Product

Table 57. REGENXBIO Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 58. REGENXBIO Recent Development

Table 59. Autolus Company Detail

Table 60. Autolus Business Overview

Table 61. Autolus Gene Therapy For Cancer Product

Table 62. Autolus Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 63. Autolus Recent Development

Table 64. American Gene Technologies Company Detail

Table 65. American Gene Technologies Business Overview

Table 66. American Gene Technologies Gene Therapy For Cancer Product

Table 67. American Gene Technologies Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 68. American Gene Technologies Recent Development

Table 69. Arcellx Company Detail

Table 70. Arcellx Business Overview

Table 71. Arcellx Gene Therapy For Cancer Product

Table 72. Arcellx Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 73. Arcellx Recent Development

Table 74. AUSTRIANOVA Company Detail

Table 75. AUSTRIANOVA Business Overview

Table 76. AUSTRIANOVA Gene Therapy For Cancer Product

Table 77. AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 78. AUSTRIANOVA Recent Development

Table 79. Alphavax Company Detail

Table 80. Alphavax Business Overview

Table 81. Alphavax Gene Therapy For Cancer Product

Table 82. Alphavax Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 83. Alphavax Recent Development

Table 84. Cellectis Company Detail

Table 85. Cellectis Business Overview

Table 86. Cellectis Gene Therapy For Cancer Product

Table 87. Cellectis Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 88. Cellectis Recent Development

Table 89. Chimeron Company Detail

Table 90. Chimeron Business Overview

Table 91. Chimeron Gene Therapy For Cancer Product

Table 92. Chimeron Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)

Table 93. Chimeron Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Therapy For Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene Therapy For Cancer Market Share by Type: 2023 VS 2030

Figure 3. Rb Gene Features

Figure 4. P53 Gene Features

Figure 5. APC Gene Features

Figure 6. NF1 Gene Features

Figure 7. Others Features

Figure 8. Global Gene Therapy For Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Gene Therapy For Cancer Market Share by Application: 2023 VS 2030

Figure 10. Cancer Treatment Case Studies

Figure 11. Tissue Repair Case Studies

Figure 12. Others Case Studies

Figure 13. Gene Therapy For Cancer Report Years Considered

Figure 14. Global Gene Therapy For Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Gene Therapy For Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Gene Therapy For Cancer Market Share by Region: 2023 VS 2030

Figure 17. Global Gene Therapy For Cancer Market Share by Players in 2023

Figure 18. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2023

Figure 20. North America Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Gene Therapy For Cancer Market Share by Country (2019-2030)

Figure 22. United States Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Gene Therapy For Cancer Market Share by Country (2019-2030)

Figure 26. Germany Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Gene Therapy For Cancer Market Share by Region (2019-2030)

Figure 34. China Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Gene Therapy For Cancer Market Share by Country (2019-2030)

Figure 42. Mexico Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Gene Therapy For Cancer Market Share by Country (2019-2030)

Figure 46. Turkey Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. GLIEAD Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 49. REGENXBIO Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 50. Autolus Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 51. American Gene Technologies Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 52. Arcellx Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 53. AUSTRIANOVA Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 54. Alphavax Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 55. Cellectis Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 56. Chimeron Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions